Disease & disorder
lacrimal duct obstruction
MONDO:0001833
Blockage of the tear duct.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Background context
Nasolacrimal duct obstruction
Nasolacrimal duct obstruction is the obstruction of the nasolacrimal ducts (better known as the tear ducts) and may be either congenital or acquired. Obstruction of the nasolacrimal ducts leads to the excess overflow of tears called epiphora.
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.